GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Optimer Pharmaceuticals Inc. (OPTR) COO and SVP Tessie M Che buys 18,000 Shares

December 29, 2009 | About:
insider

insider

56 followers
COO and SVP of Optimer Pharmaceuticals Inc. (OPTR) Tessie M Che buys 18,000 shares of OPTR on 12/29/2009 at an average price of $10.83 a share.

OPTIMER PHARMACEUTICALS, INC. is a biopharmaceutical company focused on discovering, developing & commercializing innovative anti-infective products for the treatment of serious infections. Optimer is currently focused on discovering, developing, & commercializing innovative anti-infective products in diseases of unmet needs and where current therapeutic options have limitations. Optimer has two late-stage anti-infective product candidates. OPT-80, currently in two pivotal Phase 3 clinical trials, is being developed for the treatment of Clostridium difficile infection, the most common hospital-acquired diarrhea. Prulifloxacin, also in two pivotal Phase 3 clinical trials, is an antibiotic being developed for the treatment of travelers' diarrhea, a form of infectious diarrhea. The Company has also licensed technologies and therapeutic targets from The Scripps Research Institute and The Memorial Sloan-Kettering Cancer Center. These licenses form the core of Optimer's carbohydrate Optimer Pharmaceuticals Inc. has a market cap of $360.2 million; its shares were traded at around $10.88 with and P/S ratio of 352.1.

OPTR is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC.

This is the annual revenues and earnings per share of OPTR over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of OPTR.


CEO Recent Trades:



  • Buy:: CEO and President Michael N Chang bought 18,000 shares of OPTR stock on 12/29/2009 at the average price of 10.83, the price of the stock has increased by 0.46% since.
  • Buy:: CEO and President Michael N Chang bought 15,000 shares of OPTR stock on 11/25/2009 at the average price of 11.52, the price of the stock has decreased by 5.56% since.



This is the insider trade history vs. stock price of OPTR. For the complete insider trading history of OPTR, click here.




Directors and Officers Recent Trades:



  • Buy:: VP, Clinical Development Youe Kong Shue bought 3,000 shares of OPTR stock on 12/02/2009 at the average price of 10.99, the price of the stock has decreased by 1% since.
  • Buy:: COO and SVP Tessie M Che bought 15,000 shares of OPTR stock on 11/25/2009 at the average price of 11.52, the price of the stock has decreased by 5.56% since.


About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.4/5 (7 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK